Syncing versus linking: A patient’s clinical trial journey
As precision medicines and highly individualized therapies become more common, patients are...
As precision medicines and highly individualized therapies become more common, patients are...
Most life sciences teams don't have a data shortage. They have blind spots such as patients who drop out of view, therapies that never appear in the claims they license, and clinical context that never makes it into a structured field. In a recent we...